z-logo
open-access-imgOpen Access
Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic
Author(s) -
Nan Wang,
Min Zhang,
Huajun Su,
Zhonglue Huang,
Yongbo Lin
Publication year - 2020
Publication title -
journal of international medical research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 57
eISSN - 1473-2300
pISSN - 0300-0605
DOI - 10.1177/0300060520966151
Subject(s) - medicine , fibrinolysis , myocardial infarction , percutaneous coronary intervention , thrombolysis , pandemic , cardiology , covid-19 , chest pain , tenecteplase , emergency medicine , intensive care medicine , disease , infectious disease (medical specialty)

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom